The European Multiple Sclerosis Platform (EMSP) is a Pan-European umbrella organization with over 30 years of expertise. They work together with our members and our partners to ensure that the more than 1 million people living with MS in Europe, have a real voice in determining their own priorities. They rely on a growing network of 43 member organisations from 37 European countries.
The needs of the 1 million people with MS in Europe are the main focus of their advocacy and awareness-raising campaigns to influence European decision-makers and EU policy-makers. They gather data and provide knowledge and expertise to relevant stakeholders and encourage high quality research and the dissemination of excellent, evidence-based information on MS. Their flagship projects aim to improve quality of life of people with Multiple Sclerosis, as well as to ensure that they receive high quality equitable treatment, care and can access employment.
EMSP is the only MS-specific organisation that can influence health and other EU policies. They have a history of collaboration with the European Commission and European Parliament, they are founding members of the European Patients’ Forum (EPF) and they work with the European Medicines Agency (EMA).
Learn more about EMSP here: http://www.emsp.org/ or here: http://annualreport.emsp.org/
EMSP Annual Conference 2025 May 16-17, 2025 | Hotel Don Giovanni, Prague
With 2.8 million people worldwide living with Multiple Sclerosis, this conference brings together leading experts to explore groundbreaking approaches to prevention and care of MS and related disorders. The theme Prevention in Multiple Sclerosis and Related Disorders: Uncovering Risk and Protective Factors will feature two days of knowledge sharing and collaboration among leading MS experts, healthcare providers, and patient advocates.
Key Focus Areas:
- Aging with MS and related disorders
- Managing Co-morbidities
- Inclusive Care Approaches
- Risk Factor Identification and Prevention
The distinguished speakers lineup will include a keynote session by Professor Eva Kubala Havrdová from Charles University in Prague, who will explore “Reimagining MS and Related Disorders Prevention” and healthcare system adaptations. Dr. Andrea Stennett from The Royal London Hospital will address diversity and inclusion in MS and related disorders research, while Sports Scientist Dr. Stephanie Woschek will lead one of several sessions on managing comorbidities through lifestyle interventions and holistic treatment strategies.
